Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
CRISPR Therapeutics AG
Swot
CRISPR Therapeutics AG SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
CRISPR Therapeutics AG has 10 Strengths, 8 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(8)
Opportunity
(2)
Threats
(1)
Others
(1)
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Top Losers
Mutual Funds Increased Shareholding in Past Month
MFs increased their shareholding last quarter
Institutions decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
